The selective oestrogen receptor modulation: evolution and clinical applications.
Purdie
D W
DW
Centre for Metabolic Bone Disease, Hull Royal Infirmary, Hull HU3 2RW, UK.
Beardsworth
S A
SA
D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000503:physiopathology; D017698:Postmenopause / Q000502:physiology*; D020849:Raloxifene Hydrochloride / Q000494:pharmacology*; D011960:Receptors, Estrogen / Q000502:physiology*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*
D004967:Estrogens; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride